Liu, Yongmei
Guo, Yaping
Zhan, Haoting
Liu, Xin
Li, Xiaomeng
Cui, Jingjing
Li, Haolong
Feng, Sha
Cheng, Linlin
Li, Xiaoyan
Guo, Shuqin
Li, Yongzhe
Funding for this research was provided by:
Baoding Key Laboratory of research on the pathogenicity and predictive value of autoantibodies (2163P045)
Beijing Municipal Natural Science Foundation (7234383, M23008)
China Postdoctoral Science Foundation (2023T160060)
National Key Research and Development Program of China (2018YFE0207300)
National High Level Hospital Clinical Research Funding (2022-PUMCH-B-124)
Article History
Received: 31 August 2023
Accepted: 23 July 2024
First Online: 9 August 2024
Declarations
:
: This study was approved by Medical Ethics Committee of Baoding First Central Hospital ([2022]059). Informed consents were obtained from all enrolled patients.
: The authors declare no competing interests.